Evidence map›Paper›PMID 41597332›Full record

ReviewMedicina (Kaunas, Lithuania)2025

A Review of the Latest Evidence on Prognostic Factors in Locally Advanced and Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors.

Ion Cojocaru, Mădălin Guliciuc, Elena Cojocaru, Cristina Serban, Grigore Pascaru, Mihnea Bogdan Borz, Vlad Horia Schitcu, Andrei-Ionut Tise, Iulian Osoianu, Laura-Florentina Rebegea

Abstract readReview
In one paragraph

Review in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ion CojocaruThe Clinical Department, The Faculty of Medicine and Pharmacy, "Dunarea de Jos" University of Galati, 800008 Galati, Romania.ORCID 0000-0002-5107-614X
Mădălin GuliciucThe Clinical Department, The Faculty of Medicine and Pharmacy, "Dunarea de Jos" University of Galati, 800008 Galati, Romania.
Elena CojocaruReumadiagnostic Clinic, 800402 Galati, Romania.
Cristina SerbanThe Clinical Department, The Faculty of Medicine and Pharmacy, "Dunarea de Jos" University of Galati, 800008 Galati, Romania.
Grigore PascaruThe Clinical Department, The Faculty of Medicine and Pharmacy, "Dunarea de Jos" University of Galati, 800008 Galati, Romania.
Mihnea Bogdan BorzDepartment of Anatomy, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Târgu Mureș, Romania.ORCID 0000-0002-7361-7031
Vlad Horia SchitcuUrology Department, The Oncology Institute "Ion Chiricuţă", 400015 Cluj-Napoca, Romania.ORCID 0000-0002-6735-8889
Andrei-Ionut TiseUrology Department, The Oncology Institute "Ion Chiricuţă", 400015 Cluj-Napoca, Romania.
Iulian OsoianuIoan Lascăr Municipal Hospital, 605200 Comănești, Romania.
Laura-Florentina RebegeaThe Clinical Department, The Faculty of Medicine and Pharmacy, "Dunarea de Jos" University of Galati, 800008 Galati, Romania.ORCID 0000-0002-8187-7984

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, Transitional CellImmune Checkpoint InhibitorsUrinary Bladder NeoplasmsHumansNeoplasm MetastasisPrognosisImmune Checkpoint Inhibitorsimmune checkpoint inhibitorsmetastatic urothelial carcinomaprognostic factorsurothelial carcinoma

Identifiers

PMID41597332
PMCPMC12842809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.